Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...License Agreement • November 23rd, 2022 • Gemini Therapeutics, Inc. /DE • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is made and entered into effective as of September 13, 2019 (the “Effective Date”) by and between AbbVie Deutschland GmbH & Co. KG (“AbbVie”), and Disc Medicine, Inc., a Delaware corporation (“Licensee”). AbbVie and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
DISC MEDICINE, INC. STOCK PURCHASE AND RESTRICTION AGREEMENTStock Purchase and Restriction Agreement • November 23rd, 2022 • Gemini Therapeutics, Inc. /DE • Pharmaceutical preparations • New York
Disc Medicine, Inc., a Delaware corporation (the “Company”), and AbbVie Deutschland GmbH & Co. KG (the “Purchaser”), hereby agree as follows in connection with the purchase and sale of shares of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company specified below. The terms and conditions attached hereto are incorporated herein and made a part hereof.
